BELLUS HEALTH INC. Research and Development Expense
BELLUS HEALTH INC. reported Research and Development Expense of $58.40 million for the 12-month period ending 2022-12-31, per its 40-F filed 2023-03-23.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2023-03-23
CAD
| Period end | Research And Development Expense 12 month |
|---|---|
| 2019-12-31 | 25.41M CAD 40-F · filed 2020-02-27 |
| 2018-12-31 | 6.53M CAD 40-F · filed 2020-02-27 |
USD
| Period end | Research And Development Expense 12 month |
|---|---|
| 2022-12-31 | $58.40M 40-F · filed 2023-03-23 |
| 2021-12-31 | $59.04M 40-F · filed 2023-03-23 |
| 2020-12-31 | $23.22M 40-F · filed 2022-02-23 |
| 2019-12-31 | $19.18M 40-F · filed 2021-02-25 |